Fate Therapeutics IncNASDAQ:FATE
- LAST PRICE3.6800
- TODAY'S CHANGE (%)0.2300 (6.6667%)
- Bid / Lots3.5200/ 6
- Ask / Lots4.5000/ 8
- Open / Previous Close3.4800 / 3.4500
- Day Range
- 52 Week Range
- Volume3,629,455
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FATE |
|---|---|---|
| 09:32 ET | 5552 | 3.52 |
| 09:34 ET | 2527 | 3.485 |
| 09:36 ET | 2730 | 3.56 |
| 09:38 ET | 14773 | 3.62 |
| 09:39 ET | 3990 | 3.65 |
| 09:41 ET | 19811 | 3.68 |
| 09:43 ET | 6245 | 3.685 |
| 09:45 ET | 4867 | 3.67 |
| 09:48 ET | 6083 | 3.675 |
| 09:50 ET | 4895 | 3.645 |
| 09:52 ET | 1199 | 3.655 |
| 09:54 ET | 7996 | 3.655 |
| 09:56 ET | 7680 | 3.655 |
| 09:57 ET | 4967 | 3.67 |
| 09:59 ET | 10467 | 3.665 |
| 10:01 ET | 12418 | 3.645 |
| 10:03 ET | 11810 | 3.65 |
| 10:06 ET | 17225 | 3.59 |
| 10:08 ET | 200 | 3.585 |
| 10:10 ET | 4411 | 3.55 |
| 10:12 ET | 2696 | 3.57 |
| 10:14 ET | 8025 | 3.57 |
| 10:15 ET | 4008 | 3.595 |
| 10:17 ET | 1908 | 3.615 |
| 10:19 ET | 2594 | 3.625 |
| 10:21 ET | 3205 | 3.625 |
| 10:24 ET | 10686 | 3.66 |
| 10:26 ET | 4354 | 3.635 |
| 10:28 ET | 6266 | 3.625 |
| 10:30 ET | 2150 | 3.62 |
| 10:32 ET | 2599 | 3.63 |
| 10:33 ET | 800 | 3.625 |
| 10:35 ET | 7467 | 3.615 |
| 10:37 ET | 3000 | 3.62 |
| 10:39 ET | 1300 | 3.63 |
| 10:42 ET | 1800 | 3.62 |
| 10:44 ET | 1400 | 3.6 |
| 10:46 ET | 2100 | 3.61 |
| 10:48 ET | 3140 | 3.5832 |
| 10:50 ET | 3522 | 3.58 |
| 10:51 ET | 4659 | 3.6 |
| 10:53 ET | 4087 | 3.6 |
| 10:55 ET | 2606 | 3.61 |
| 10:57 ET | 1724 | 3.6195 |
| 11:00 ET | 4725 | 3.63 |
| 11:02 ET | 17463 | 3.62 |
| 11:04 ET | 11020 | 3.5894 |
| 11:06 ET | 293 | 3.58 |
| 11:08 ET | 7786 | 3.585 |
| 11:09 ET | 3011 | 3.6 |
| 11:11 ET | 6900 | 3.5999 |
| 11:13 ET | 2026 | 3.605 |
| 11:15 ET | 2900 | 3.585 |
| 11:18 ET | 4034 | 3.59 |
| 11:20 ET | 1553 | 3.58 |
| 11:22 ET | 300 | 3.58 |
| 11:24 ET | 1037 | 3.575 |
| 11:26 ET | 426 | 3.58 |
| 11:27 ET | 700 | 3.578 |
| 11:29 ET | 1661 | 3.575 |
| 11:31 ET | 4874 | 3.585 |
| 11:33 ET | 5186 | 3.5845 |
| 11:36 ET | 626 | 3.585 |
| 11:38 ET | 800 | 3.585 |
| 11:40 ET | 1400 | 3.58 |
| 11:42 ET | 4028 | 3.575 |
| 11:44 ET | 1740 | 3.58 |
| 11:45 ET | 2700 | 3.5799 |
| 11:47 ET | 2112 | 3.585 |
| 11:49 ET | 800 | 3.59 |
| 11:51 ET | 800 | 3.59 |
| 11:54 ET | 4600 | 3.575 |
| 11:56 ET | 5215 | 3.575 |
| 12:00 ET | 5030 | 3.56 |
| 12:02 ET | 1228 | 3.555 |
| 12:03 ET | 1400 | 3.545 |
| 12:05 ET | 3632 | 3.555 |
| 12:07 ET | 2100 | 3.545 |
| 12:12 ET | 1524 | 3.5499 |
| 12:14 ET | 2638 | 3.52 |
| 12:16 ET | 6784 | 3.535 |
| 12:18 ET | 2014 | 3.54 |
| 12:20 ET | 2138 | 3.54 |
| 12:21 ET | 23991 | 3.545 |
| 12:23 ET | 1334 | 3.54 |
| 12:25 ET | 100 | 3.535 |
| 12:27 ET | 1996 | 3.545 |
| 12:30 ET | 1100 | 3.535 |
| 12:32 ET | 200 | 3.535 |
| 12:34 ET | 758 | 3.535 |
| 12:36 ET | 6952 | 3.535 |
| 12:38 ET | 725 | 3.535 |
| 12:39 ET | 1406 | 3.54 |
| 12:41 ET | 200 | 3.54 |
| 12:43 ET | 4723 | 3.515 |
| 12:45 ET | 1200 | 3.52 |
| 12:48 ET | 1058 | 3.51 |
| 12:50 ET | 600 | 3.52 |
| 12:52 ET | 500 | 3.52 |
| 12:54 ET | 500 | 3.52 |
| 12:56 ET | 5102 | 3.53 |
| 12:57 ET | 600 | 3.525 |
| 12:59 ET | 10509 | 3.52 |
| 01:01 ET | 100 | 3.52 |
| 01:03 ET | 5487 | 3.54 |
| 01:06 ET | 2312 | 3.53 |
| 01:08 ET | 600 | 3.53 |
| 01:10 ET | 1416 | 3.53 |
| 01:12 ET | 3900 | 3.535 |
| 01:14 ET | 7026 | 3.5332 |
| 01:15 ET | 300 | 3.54 |
| 01:17 ET | 1609 | 3.53 |
| 01:19 ET | 10792 | 3.535 |
| 01:24 ET | 4072 | 3.545 |
| 01:26 ET | 600 | 3.55 |
| 01:28 ET | 8230 | 3.555 |
| 01:30 ET | 400 | 3.56 |
| 01:32 ET | 200 | 3.555 |
| 01:33 ET | 3630 | 3.56 |
| 01:35 ET | 6171 | 3.55 |
| 01:37 ET | 200 | 3.55 |
| 01:39 ET | 600 | 3.54 |
| 01:42 ET | 4130 | 3.535 |
| 01:44 ET | 5500 | 3.54 |
| 01:46 ET | 6608 | 3.55 |
| 01:48 ET | 1498 | 3.55 |
| 01:50 ET | 900 | 3.545 |
| 01:51 ET | 13322 | 3.57 |
| 01:53 ET | 5465 | 3.56 |
| 01:55 ET | 635 | 3.56 |
| 01:57 ET | 200 | 3.56 |
| 02:00 ET | 420 | 3.56 |
| 02:02 ET | 42092 | 3.585 |
| 02:04 ET | 6445 | 3.575 |
| 02:06 ET | 9762 | 3.58 |
| 02:08 ET | 6333 | 3.59 |
| 02:09 ET | 6964 | 3.615 |
| 02:11 ET | 8903 | 3.61 |
| 02:13 ET | 2125 | 3.62 |
| 02:15 ET | 2773 | 3.6 |
| 02:18 ET | 434 | 3.61 |
| 02:20 ET | 3306 | 3.615 |
| 02:22 ET | 700 | 3.615 |
| 02:24 ET | 9521 | 3.63 |
| 02:26 ET | 100 | 3.63 |
| 02:27 ET | 700 | 3.625 |
| 02:29 ET | 1400 | 3.63 |
| 02:31 ET | 8210 | 3.615 |
| 02:33 ET | 7415 | 3.63 |
| 02:36 ET | 6455 | 3.635 |
| 02:38 ET | 3205 | 3.64 |
| 02:40 ET | 3404 | 3.64 |
| 02:42 ET | 2272 | 3.64 |
| 02:44 ET | 30560 | 3.645 |
| 02:45 ET | 13412 | 3.645 |
| 02:47 ET | 38657 | 3.63 |
| 02:49 ET | 17142 | 3.635 |
| 02:51 ET | 4644 | 3.635 |
| 02:54 ET | 9666 | 3.625 |
| 02:56 ET | 2300 | 3.63 |
| 02:58 ET | 15764 | 3.65 |
| 03:00 ET | 5159 | 3.65 |
| 03:02 ET | 2304 | 3.65 |
| 03:03 ET | 9483 | 3.655 |
| 03:05 ET | 3944 | 3.66 |
| 03:07 ET | 20715 | 3.65 |
| 03:09 ET | 1412 | 3.655 |
| 03:12 ET | 1273 | 3.655 |
| 03:14 ET | 916 | 3.655 |
| 03:16 ET | 3587 | 3.65 |
| 03:18 ET | 1000 | 3.655 |
| 03:20 ET | 10108 | 3.65 |
| 03:21 ET | 1200 | 3.65 |
| 03:23 ET | 1200 | 3.655 |
| 03:25 ET | 1300 | 3.66 |
| 03:27 ET | 1392 | 3.66 |
| 03:30 ET | 13435 | 3.645 |
| 03:32 ET | 3200 | 3.645 |
| 03:34 ET | 17784 | 3.665 |
| 03:36 ET | 1544 | 3.67 |
| 03:38 ET | 2286 | 3.665 |
| 03:39 ET | 7793 | 3.66 |
| 03:41 ET | 6732 | 3.66 |
| 03:43 ET | 4300 | 3.66 |
| 03:45 ET | 7052 | 3.67 |
| 03:48 ET | 10917 | 3.66 |
| 03:50 ET | 4030 | 3.66 |
| 03:52 ET | 42748 | 3.68 |
| 03:54 ET | 9238 | 3.695 |
| 03:56 ET | 54618 | 3.69 |
| 03:57 ET | 46113 | 3.68 |
| 03:59 ET | 80379 | 3.68 |
May 29, 2024
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference, from 4:01PM ET on Wednesday May 29, 2024 by Dow Jones
4:01PM ET on Wednesday May 29, 2024 by Dow Jones
May 16, 2024
DJ Fate Therapeutics Is Maintained at Neutral by HC Wainwright & Co., from 7:49AM ET on Thursday May 16, 2024 by Dow Jones
7:49AM ET on Thursday May 16, 2024 by Dow Jones
May 10, 2024
DJ Fate Therapeutics Is Maintained at Buy by Canaccord Genuity, from 2:48PM ET on Friday May 10, 2024 by Dow Jones
2:48PM ET on Friday May 10, 2024 by Dow JonesDJ Fate Therapeutics Is Maintained at Market Perform by BMO Capital, from 11:27AM ET on Friday May 10, 2024 by Dow Jones
11:27AM ET on Friday May 10, 2024 by Dow JonesDJ Fate Therapeutics Is Maintained at Neutral by Piper Sandler, from 9:28AM ET on Friday May 10, 2024 by Dow Jones
9:28AM ET on Friday May 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fate Therapeutics Inc | 418.9M | -1.9x | --- |
Editas Medicine Inc | 427.6M | -2.5x | --- |
Contineum Therapeutics Inc | 394.1M | 20.1x | --- |
ADC Therapeutics SA | 329.9M | -1.2x | --- |
Poseida Therapeutics Inc | 289.9M | -2.5x | --- |
Adaptimmune Therapeutics PLC | 288.8M | -1.6x | --- |
Company Information
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Contact Information
- Headquarters
- 12278 Scripps Summit DriveSAN DIEGO, CA, United States 92131
- Phone
- 858-875-1803
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- William Rastetter
- President, Chief Executive Officer, Director
- John Wolchko
- Independent Vice Chairman of the Board
- John Mendlein
- Chief Financial Officer
- Edward Dulac
- General Counsel and Corporate Secretary
- Cindy Tahl
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $418.9M |
|---|---|
Revenue (TTM) | $6.5M |
Shares Outstanding | 113.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.90 |
EPS | $-1.92 |
Book Value | $3.74 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 64.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,287.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
